Results 21 to 30 of about 58,975,883 (160)

LINFOMA T ANGIOIMUNOBLÁSTICO COM PRESENÇA DE IMUNOBLASTOS REACIONAIS EM SANGUE PERIFÉRICO - RELATO DE CASO

Hematology, Transfusion and Cell Therapy, 2023
Objetivo: Descrição de caso de paciente com linfoma angioimunoblástico T com células anômalas circulantes em sangue periférico demonstradas por imunofenotipagem por citometria de fluxo.
TFN Araujo, ML Puls, BA Souza, CFM Ferreira, RS Szor, VA Silva, VC Molla, PHA Moraes, CAR Silva   +8 more
doaj   +1 more source

Altas Doses de VP-16, Ciclofosfamida e Irradiação Corpórea Total Hiperfracionada Seguida de Transplante Alogeneico de Medula óssea: Um Regime Agressivo e Bem Tolerado no Tratamento de Neoplasias Hematológicas de Mau Prognóstico – Resultados Preliminares

Revista Brasileira de Cancerologia, 2023
No período de agosto/86 a fevereiro/87, três pacientes foram tratados com VP-16-1800mg/m2, em infusão única em 26 horas no dia -6, seguida por Ciclo fosfamida (EDX) 50mg/kg/d nos dias -4 e -3.
Daniel G. Tabak, Luiz Fernando da S. Bouzas, Luis Souhami, M. Kadma da S. Carriço, Mary Evelyn D. Flowers   +4 more
doaj   +1 more source

VI Consensus of the Brazilian Society of Bone Marrow Transplantation (SBTMO) - Consensus on Graft-versus-Host Disease (GVHD)

Journal of Bone Marrow Transplantation and Cellular Therapy, 2023
In this 2022 Update of Version 2020 of the VI Consensus of the Brazilian Society of Bone Marrow Transplantation (SBTMO) for Graft-versus-Host-Disease (GVHD), we seek to provide evidence-based guidance on all the novel and clinically relevant ...
Vaneuza A. M. Funke, Maria Cláudia R. Moreira, Antonio Vaz de Macedo, Andresa Melo, Jayr Schmidt Filho, Giancarlo Fatobene, Rita de Cássia B. S. Tavares, Marcia M. Silva, Maria Cristina M. Almeida Macedo, Marcos Paulo Colella, Vergilio A. R. Colturato, Mair Pedro de Souza, Morgani Rodrigues, João Victor Piccolo Feliciano, Luis Fernando S. Bouzas, Afonso Celso Vigorito   +15 more
doaj   +1 more source

DESCRIPTIVE ANALYSIS OF HEMATOPOIETIC STEM CELL TRANSPLANTS PERFORMED IN A PUBLIC SERVICE BETWEEN 1984 AND 2023

Hematology, Transfusion and Cell Therapy, 2023
Introduction: Hematopoietic Stem Cell Transplantation (HSCT) is a treatment modality for some benign and/or malignant diseases that affect blood cells. The first successful HSCT took place in the USA in 1957 and later in Brazil in 1979.
LC Costa-Junior, M Izu, JDC Salgado, PCJ Lim-Santos, MC Rodrigues-Moreira, D Lerner   +5 more
doaj   +1 more source

Haploidentical Stem Cell Transplantation With Dual Source of Cells and Post-Transplant Cyclophosphamide. [PDF]

Cancer Med
ABSTRACT Background Dual sources of cells (DSC) with peripheral blood stem cell apheresis (PBSC) and surgical bone marrow (BM) for haploidentical hematopoietic cell transplantation (Hid‐HCT) are used in China and some Asian countries. The experience of the Baltimore group for haploidentical transplant with post‐transplant cyclophosphamide (PT‐Cy) and ...
Fonseca-Hial AMR, Parisio K, de Oliveira JSR.   +2 more
europepmc   +2 more sources

Health‐related Quality of Life Profile of Newly Diagnosed Patients With Myelodysplastic Syndromes by Age, Sex, and Risk Group: A Real‐world Study by the GIMEMA

HemaSphere, Volume 7, Issue 9, September 2023., 2023
Health‐related quality of life (HRQoL) is an important goal of therapy for patients with myelodysplastic syndromes (MDS); however, little is known about HRQoL of these patients at clinical presentation. We report HRQoL profile of newly diagnosed patients with MDS across both the the International Prognostic Scoring System (IPSS) and IPSS‐Revised (IPSS ...
Fabio Efficace, Wael Al Essa, Uwe Platzbecker, Pasquale Niscola, Giuseppe A. Palumbo, Giovanni Caocci, Francesco Cottone, Massimo Breccia, Mario Luppi, Reinhard Stauder, Alessandra Ricco, Duska Petranovic, Frederic Baron, Maria Teresa Voso, Luana Fianchi, Chiara Frairia, Isabella Capodanno, Chiara Sarlo, Marilena Fedele, Roberto Massimo Lemoli, Rosangela Invernizzi, Daniele Vallisa, Nicola Di Renzo, Claudio Fozza, Maribel Doro, Johannes M. Giesinger, Marco Vignetti   +26 more
wiley   +1 more source

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

HemaSphere, Volume 5, Issue 7, July 2021., 2021
Mutations in the calreticulin (CALR) gene are seen in about 30% of essential thrombocythemia and primary myelofibrosis patients. To address the contribution of the human CALR mutants to the pathogenesis of myeloproliferative neoplasms (MPNs) in an endogenous context, we modeled the CALRdel52 and CALRins5 mutants by induced pluripotent stem cell (iPSC ...
Lise Secardin, Cintia Gomez Limia, Suzana da Silva‐Benedito, Larissa Lordier, Mira El‐Khoury, Caroline Marty, Jean‐Christophe Ianotto, Hana Raslova, Stefan N. Constantinescu, Martín Hernán Bonamino, William Vainchenker, Barbara Monte‐Mor, Antonio Di Stefano, Isabelle Plo   +13 more
wiley   +1 more source

Análise epidemiológica dos procedimentos cirúrgicos por transplante de células-tronco hematopoiéticas de medula óssea: autogênico versus alogênico [PDF]

, 2022
Os transplantes de medula óssea, são uma modalidade terapêutica que permite a utilização de altas doses de quimioterápicos, devido a possibilidade da infusão de células tronco hematopoiéticas, para reverter a toxicidade causada pelas drogas utilizadas na
Cezário Costa Reis, Bruno, Cristine da Silva Sant'Ana, Isabella   +1 more
core   +1 more source

miRNome Profiling Reveals Shared Features in Breast Cancer Subtypes and Highlights miRNAs That Potentially Regulate MYB and EZH2 Expression

Frontiers in Oncology, 2021
Breast cancer (BC) has been extensively studied, as it is one of the more commonly diagnosed cancer types worldwide. The study of miRNAs has increased what is known about the complexity of pathways and signaling and has identified potential biomarkers ...
Stephany Corrêa, Francisco P. Lopes, Carolina Panis, Thais Basili, Thais Basili, Renata Binato, Eliana Abdelhay   +6 more
doaj   +1 more source

Relato de experiência: abordagem multidisciplinar na anemia aplástica – desenvolvimento de um modelo de assistência ambulatorial

HU Revista, 2021
Introdução: A anemia aplástica é uma doença hematológica rara, que cursa com alta morbidade e mortalidade. O tratamento é definido pela idade do paciente, classificação da gravidade, comorbidades existentes e disponibilidade de um doador compatível para ...
Adriana Aparecida Ferreira, Camila Mariana de Araújo Silva Vieira, Débora Wagner, Flávio Rodrigues Reis   +3 more
doaj   +1 more source